H-DL-Gly-OBzl HCl

CAS No. 2462-31-9

H-DL-Gly-OBzl HCl( —— )

Catalog No. M32714 CAS No. 2462-31-9

Compound Fr13877 is a useful organic compound for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    H-DL-Gly-OBzl HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Compound Fr13877 is a useful organic compound for research related to life sciences.
  • Description
    H-DL-Gly-OBzl (hydrochloride) is a Glycine (HY-Y0966) derivative.
  • In Vitro
    Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2462-31-9
  • Formula Weight
    922.03
  • Molecular Formula
    C49H59N7O11
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (495.91 mM; Ultrasonic )
  • SMILES
    Cl.NCC(=O)OCC1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.?
molnova catalog
related products
  • Substance P (1-7)(TF...

    Substance P (1-7)(TFA) is a fragment of the neuropeptide, substance P (SP).

  • Isonardosinone

    Isonardosinone shows potential role in the treatment of neuroinflammation conditions, it inhibits NF-?oB- and MAPK-mediated inflammatory pathways.

  • PAC1R antagonist 1

    PAC1R antagonist 1 is an orally active PAC1 receptor antagonist that inhibits abnormal pain induced by pituitary adenylate cyclase-activating polypeptide (PACAP) and nerve damage, and may be used in the study of neoplasms and immune-related disorders.